Results 131 to 140 of about 22,933 (184)

The Association of Chronic Pulmonary Aspergillosis and Chronic Pulmonary Histoplasmosis with MDR-TB Patients in Indonesia. [PDF]

J Fungi (Basel)
Soeroso NN, Siahaan L, Khairunnisa S, Anggriani RAH, Aida A, Eyanoer PC, Daulay ER, Burhan E, Rozaliyani A, Ronny R, Adawiyah R, Denning DW, Wahyuningsih R.   +12 more
europepmc   +1 more source

Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa. [PDF]

Int J Tuberc Lung Dis
Geiger K, Patil A, Bergman A, Budhathoki C, Heidari O, Lowensen K, Mthimkhulu N, McNabb KC, Mmed NN, Ngozo J, Reynolds N, Farley JE.   +11 more
europepmc   +1 more source

Diagnostic Accuracy of BD MAX MDR-TB Assay Performed on Bronchoscopy Specimens in Patients with Suspected Pulmonary Tuberculosis. [PDF]

Tuberc Respir Dis (Seoul)
Ko SJ, Yoon KH.
europepmc   +1 more source

Examining the challenges in sustaining user engagement with a mobile app to enhance multidrug-resistant tuberculosis (MDR-TB) care in Vietnam and its implications for implementing person-centred mHealth interventions. [PDF]

PLOS Glob Public Health
Drabarek D, Trinh-Hoang D, Yapa M, Dang TTH, Vu HD, Nguyen TA, Do TT, Nguyen BH, Vu DH, Fox GJ, Bernays S.   +10 more
europepmc   +1 more source

Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study. [PDF]

Bioanalysis
Gao T, Ou X, Miao J, Qin Y.
europepmc   +1 more source

On the onset and dispersal of a major MDR TB clone among HIV-negative patients, Tunisia. [PDF]

Antimicrob Resist Infect Control
Dekhil N, Mardassi H.
europepmc   +1 more source

Factors Associated with Non-Adherence to Treatment Among Migrants with MDR-TB in Wuhan, China: A Cross-Sectional Study. [PDF]

Risk Manag Healthc Policy
Lin K, Xiang L.
europepmc   +1 more source

Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China. [PDF]

Ann Med
Gu P, Lu P, Ding H, Liu Q, Ding X, Chen Y, Zhu L.   +6 more
europepmc   +1 more source

Performance evaluation of alternative bacteriological measures of response to MDR-TB therapy during the initial 16 weeks of treatment

Ssengooba W, Musisi E, Semugenze D, Komakech K, Ndema M, Sekaggya CW, Adakun S, Sloan DJ, Katamba A, Lamorde M, Joloba M, Sabiiti W.   +11 more
europepmc   +1 more source